Why the study?
Neonatal atrial flutter can cause heart failure in newborns, but little is known about catheter ablation in this population.
Does catheter ablation prevent recurrence in a neonate with refractory atrial flutter and tachycardiomyopathy?
Does catheter ablation prevent recurrence in a neonate with refractory atrial flutter and tachycardiomyopathy?
Catheter ablation is a feasible and potentially long-lasting treatment option for refractory atrial flutter in neonates.
Requires caution before adopting neonatal atrial flutter ablation; leaves open its efficacy and safety in broader populations.
Background: Fetal echocardiography can diagnose neonatal atrial flutter, which can cause heart failure in newborns. Little is known about catheter ablation in this population. Methods: Case report that aimed to review a successful ablation in a 20-day-old patient with refractory atrial flutter. Results: This is the first report of a successful neonatal atrial flutter ablation without any early recurrence after the procedure. Conclusions: Atrial flutter ablation performed on newborns is a reliable and long-lasting treatment option.
No takes yet. Share an insight, caveat, or question.
Leiria et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: